Forest Settles With Spitzer, Will Post All Phase III-IV Results On-Line
This article was originally published in The Pink Sheet Daily
Executive Summary
Forest Labs has agreed to post summaries of all Phase III and Phase IV trials on the Internet to resolve an investigation into the company by New York Attorney General Eliot Spitzer
You may also be interested in...
Forest Clinical Trials Registry Launches With Antidepressant Data
Forest's registry website, required under a settlement with the New York Attorney General, currently includes summaries of pediatric and adolescent studies of Lexapro and Celexa, and listings for all of Forest's open Phase III and IV trials.
Forest Clinical Trials Registry Launches With Antidepressant Data
Forest's registry website, required under a settlement with the New York Attorney General, currently includes summaries of pediatric and adolescent studies of Lexapro and Celexa, and listings for all of Forest's open Phase III and IV trials.
N.Y. AG Spitzer Criticizes FDA "Silence" On Disclosing Rx Trial Data
In a speech at the National Press Club, Eliot Spitzer discusses his lawsuit against GlaxoSmithKline that resulted in a settlement in which the company will publicly disclose clinical trial data. He says FDA "has not said a word" that would require other drug manufacturers to do the same.